SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Bankr is an advanced AI agent focused on simplifying the process of buying and selling digital assets. Bankr was the first AI agent on Farcaster to help you quickly buy all your favorites coins directly in the social. BankrCoin is the official coin of the agent and was deployed by Bankr itself directly in the Farcaster social feed. Fees from swaps go to support BankrCoin. Bankr is available on Farcaster and will soon be launching a private terminal, token recs, and limit orders on Base.

BankrCoin

BankrCoin is capturing significant community attention as users highlight its expanding AI-driven infrastructure and active revenue-generating agents on the Base network. Investors are actively discussing the token's potential for long-term utility-based growth, frequently pointing to recent ecosystem updates and development velocity as reasons to accumulate during price fluctuations.

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The Pharmaceutical Compounding segment focuses on the operations of the ImprimisRx business. The company was founded by Mark L. Baum and Robert J. Kammer on January 11, 2006 and is headquartered in Nashville, TN.

Harrow Inc

Harrow Health Inc

Harrow Health is trending as institutional interest builds around its Ophthalmic platform and the favorable formulary status of VEVYE, leading to strong community conviction that the company is at a historic inflection point. Investors are closely monitoring record prescription growth and sales force expansion as primary catalysts to drive the stock toward long-term targets.

TMC the metals co., Inc. is a deep-sea minerals exploration company focused on the collection and processing of polymetallic nodules found on the seafloor in international waters of the Clarion Clipperton Zone in the Pacific Ocean (CCZ). These nodules contain high grades of four metals (nickel, copper, cobalt, manganese) which can be used as (i) feedstock for battery cathode precursors (nickel, cobalt and manganese sulfates, or intermediate nickel-copper-cobalt matte) for electric vehicles (EV) and renewable energy storage markets, (ii) copper cathode for EV wiring, energy transmission and other applications and (iii) manganese silicate for manganese alloy production required for steel production. The company was founded in 2021 and is headquartered in Vancouver, Canada.

TMC the metals company Inc

TMC is trending due to a major de-risking catalyst as the company finalized a commercial agreement with Allseas to develop and operate its first offshore nodule collection system, with Allseas funding a significant portion of development costs. The community is actively discussing the stock's long-term potential as a critical minerals leader, the implications for upcoming earnings, and recent patterns of institutional accumulation despite ongoing volatility.

Canary XRP ETF - Common Shares of Beneficial Interest

Canary XRP ETF

The XRP ecosystem is experiencing a surge in activity driven by optimism surrounding the CLARITY Act and significant institutional interest in spot ETFs. Investors are actively discussing the potential for increased liquidity, the role of XRP in bridging traditional and digital finance, and the impact of sustained ETF inflows on market supply.

Corgi ETF Trust I. - Corgi Lithography & Semiconductor Photonics ETF

Corgi Lithography & Semiconductor Photonics ETF

Investors are rapidly flocking to the recently launched Corgi Lithography & Semiconductor Photonics ETF due to its exposure to the critical infrastructure enabling AI compute. The community is actively discussing the fund's fast-growing assets under management and its role as a strategic companion to memory-focused ETFs in the semiconductor supply chain.

Volatility Shares Trust - Volatility Shares Trust XRP ETF

XRP ETF

The community is heavily focused on XRP following progress with the CLARITY Act, which seeks to clarify the asset's regulatory status as a digital commodity. Investors are actively discussing the potential impact of this legislative momentum, alongside institutional integration news and the growth of XRP-linked exchange-traded products.

Bitwise XRP ETF - Common Shares Of Beneficial Interest

Bitwise XRP ETF

XRP is trending as investors digest the advancement of the CLARITY Act, which seeks to clarify the digital asset's regulatory status, while enthusiasm grows around the increasing institutional adoption fueled by the Bitwise XRP ETF and Ripple's expanding payment infrastructure. Community discussions are heavily focused on navigating current market volatility, analyzing long-term utility for cross-border settlements, and debating the potential impact of legislative developments on future price momentum.

Amentum Holdings, Inc. engages in mission-critical, technology-driven services in government and commercial markets. It operates through the Digital Solutions and Global Engineering Solutions segments. The Digital Solutions segment provides advanced digital and data-driven solutions including intelligence analytics, space system development, cybersecurity, and next generation IT. The Global Engineering Solutions segment manages large-scale environmental remediation, nuclear power solutions, platform engineering, sustainment and supply chain management. The company was founded on November 26, 2019 and is headquartered in Chantilly, VA.

Amentum Holdings Inc.

Amentum Holdings is experiencing significant volatility as investors weigh strong backlog growth and a series of contract wins against a broader sector-wide slump. While the community is actively debating the company's long-term valuation and potential for a breakout, ongoing selling pressure is keeping sentiment cautious despite positive earnings commentary.

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.

Boston Scientific Corp.

Boston Scientific is gaining strong market attention as investors weigh its robust cardiovascular growth and recent regulatory approvals against ongoing short-term volatility. The community is actively debating the company's valuation following a series of analyst downgrades, while many long-term bulls continue to view the current price as a strategic accumulation opportunity driven by its dominant position in medical device innovation.

Tempus AI, Inc. is a healthcare technology company, which engages in bringing artificial intelligence and machine learning to healthcare. It focuses on building platforms for oncology, neuropsychiatry, cardiology, infectious disease, and radiology. The company was founded by Eric Paul Lefkofsky in August 2015 and is headquartered in Chicago, IL.

Tempus AI Inc. - Ordinary Shares - Class A

Tempus AI Inc

Tempus AI is experiencing significant downward pressure as investors debate the impact of negative insider trading patterns and recent class-action litigation involving data privacy. Despite these concerns, bullish sentiment persists among some community members who point to the company's expanding partnerships with major pharmaceutical firms and continued accumulation by prominent institutional investors as indicators of long-term upside potential.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Quality Over Hype: Investing Wisely for the Long Term

Nancy Tengler shares her market outlook and favorite stocks.

Retail sentiment for American Express brightened on Friday after the firm raised its full year earnings guidance while reporting a mixed set of earnings. The credit card giant raised its full-year earnings per share (EPS) guidance to $13.30 - $13.80 from $12.65 - $13.15 previously.American Express also stated that it continues to expect revenue growth in line with the guidance range of 9%to 11% set at the beginning of the year. Retail sentiment on the stock is currently trending in bullish territory (60/100) supported by an extremely high message volume.<figure class="image"><img style="aspect-ratio:787/236;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/Screenshot_2024_07_19_at_9_49_19_AM_97f070487a.png" alt="Retail sentiment for American Express stock trends in bullish territory" width="787" height="236"><figcaption>Retail sentiment for American Express stock trends in bullish territory</figcaption></figure>For the second quarter, the firm reported a 9% rise in its total revenues net of interest expense (forex adjusted) at $16.33 billion, which came in lower than a Street estimate of $16.59 billion. American Express said the rise in revenues was primarily driven by higher net interest income, increased card member spending, and continued strong card fee growth.Network volumes increased 3% YoY to $440.60 billion during the quarter. The average fee per card increased to $101 compared to $91 in the same period last year. Active spending by the firm’s premium customers at a time when recession fears are fading has helped the firm keep up the earnings.Stephen J. Squeri, Chairman and Chief Executive Officer at American Express said that an increased scale, combined with premium, high credit quality customers, well-controlled expense base and successful investments to continuously enhance the firm’s membership model, fuels the earnings power of the core business. This has reinforced the company’s confidence in its ability to deliver strong bottom-line growth, he said.Earnings per share rose 21% year-over-year (YoY) to $3.49, higher than a Street estimate of $3.24. Net income rose 39% YoY to $3.02 billion.Amidst all the upbeat numbers, the only blip was an increase in the consolidated provisions for credit losses that came in at &nbsp;$1.30 billion, compared with $1.20 billion a year ago. The increase reflected higher net write-offs, partially offset by a lower reserve build YoY, the firm said.Squeri added that based on the strong performance of its core business, the firm believes it can increase its marketing investments by around 15% YoY without using any of the transaction gain, allowing it to drive the “profitable growth” that investors love to see.American Express shares were trading nearly 2% lower in Friday’s pre-market session. The stock has performed well this year, having returned over 32% on a year-to-date basis. Based on current retail sentiment, it’s likely that at least some investors are looking to use this weakness to add to their longer-term positions.&nbsp;&nbsp;

Why American Express Drew Positive Retail Sentiment After Earnings Announcement

Although revenue came in lower than a Street estimate, its second quarter earnings beat estimates and the firm raised its full-year earnings guidance. 

Equity

Although revenue came in lower than a Street estimate, its second quarter earnings beat estimates and the firm raised its full-year earnings guidance. Retail investors and traders remain upbeat about the firm’s longer-term bet on the higher-income consumer.

Current Price	$39.34
Prev Close	$39.76
Open	$39.53
Dividend Yield	N/A
50-Day Moving Average	$37.76
Beta	N/A
Avg. Volume	11,837.44
PE Ratio	N/A

52-Week High	$39.90
52-Week Low	$29.59
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

TGLR
Wedbush Series Trust - Wedbush LAFFER TENGLER New Era Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest TGLR News

TGLRWedbush Series Trust - Wedbush LAFFER TENGLER New Era Value ETF